Abstract #4031
Intratracheal administration of ultra-small Gd-based nanoparticles: a new protocol for brain tumor targeting
Andrea Bianchi 1 , Damien Moncelet 1 , Franois Lux 2 , Emeline Julie Ribot 1 , Nawal Tassali 1 , Veronique Bouchaud 1 , Olivier Tillement 2 , Pierre Voisin 1 , and Yannick Crmillieux 1
1
Centre de Rsonance Magntique des Systmes
Biologiques, Universit Bordeaux Segalen, Bordeaux,
Bordeaux, France,
2
Institut
Lumire Matire, Universit Claude Bernard, Lyon, France
Glioblastoma is the most aggressive, common and lethal
brain tumor. In this context, new noninvasive methods
for early detection and therapy are needed in order to
improve the prognosis of this pathology. We present here
an in vivo MRI longitudinal study of brain cancer
detection in tumor-bearing immunodeficient mice through
intratracheally- and intravenously- administered
multimodal Ultra-Small Rigid Platforms. In this study we
showed for the first time that the synergic employment
of a strongly T1-weighted MRI UTE sequence and
intratracheally-administered gadolinium-based
nanoparticles allow the high-precision detection of
brain tumor and of its contours.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
